Syros Pharmaceuticals (SYRS) announced Wednesday positive initial data from its ongoing SELECT-AML-1 Phase 2 trial evaluating tamibarotene, in combination with venetoclax and azacitidine in newly diagnosed, unfit patients with acute myeloid leukemia or AML and RARA gene overexpression. In pre-market activity on Nasdaq, the shares were gaining around 10 percent […]
Read moreGold Prices Climb Higher As Dollar Weakens
Gold prices moved higher on Friday, earning the most active gold futures contract their second straight weekly gain, as the dollar shed ground. Despite some hawkish comments from a few Fed officials, there are expectations the central bank will start reducing rates beginning in the second quarter of 2024. The […]
Read moreOil Futures Settle Lower As Higher Inventory, OPEC Meet Postponement Weigh
Crude oil futures settled lower on Wednesday after data showed a notable increase in crude inventory in the U.S., and the Organization of Petroleum Exporting Countries (OPEC) postponed a key meeting by four days. OPEC and allies, collectively known as OPEC+, were scheduled to meet on Sunday (November 26) to […]
Read moreTreasuries Skyrocket Following Tamer Than Expected Inflation Data
After closing roughly flat for two consecutive sessions, treasuries showed a substantial move to the upside during trading on Tuesday. Bond prices skyrocketed early in the trading day and remained sharply higher throughout the session. As a result, the yield on the benchmark ten-year note, which moves opposite of its […]
Read moreBank bosses cut loose in a war of words
Save articles for later Add articles to your saved list and come back to them any time. Now that all the major banks have reported their 2023 profits, the conventional notion that Australia’s big four lenders act as a herd is being challenged. Far from acting as an oligopoly, there […]
Read moreSavings accounts finally beat inflation as cheap money era ends
Save articles for later Add articles to your saved list and come back to them any time. Interest rates are breaking through a key barrier: it’s now possible to make returns that are slightly above inflation simply by putting your money in the bank. Until recently, holding money in a […]
Read moreWeaker Than Expected Jobs Data Leads To Extended Rally By Treasuries
Treasuries moved sharply higher during trading on Friday, extending the strong upward move seen over the two previous sessions. Bond prices gave back ground after an early rally but remained firmly in positive territory. Subsequently, the yield on the benchmark ten-year note, which moves opposite of its price, tumbled by […]
Read moreTreasuries Move Sharply Lower Ahead Of Key Economic Data
After ending the previous session little changed, treasuries moved sharply lower over the course of the trading day on Wednesday. Bond prices came under pressure in early trading and saw further downside as the day progressed. As a result, the yield on the benchmark ten-year note, which moves opposite of […]
Read moreGold Futures Settle Modestly Higher Ahead Of Key Economic Data
Gold prices climbed higher on Wednesday on safe-haven appeal amid the ongoing conflict in the Middle East. Investors kept a wary eye on the situation in the Middle East amidst reports of an imminent ground invasion of Gaza by Israel. A stronger dollar, and higher bond yields limited the yellow […]
Read moreMerck Reveals Positive Results From Phase 3 KEYTRUDA Trials In Various Cancers
Drug major Merck & Co., Inc. (MRK) Friday announced positive results of Phase 3 trials with its anti-PD-1 therapy KEYTRUDA (pembrolizumab) in various cancers. In the Phase 3 KEYNOTE-756 trial, KEYTRUDA in combination with chemotherapy showed statistically significant improvement in pathological complete response or pCR rate as neoadjuvant therapy versus […]
Read more